BACKGROUND: In pediatric patients with anxiety disorders, existing symptom inventories are either not freely available or require extensive time and effort to administer. We sought to evaluate a brief self-report scale-the Generalized Anxiety Disorder 7-item scale (GAD-7)-in adolescents with generalized anxiety disorder (GAD). METHODS: The Pediatric Anxiety Rating Scale (PARS) and the GAD-7 were administered to youth with GAD (confirmed by structured interview). Relationships between the measures were assessed, and sensitivity and specificity was determined with regard to a global symptom severity measure (Clinical Global Impression-Severity). RESULTS: In adolescents with GAD (N = 40; mean age, 14.8 ± 2.8), PARS and GAD-7 scores strongly correlated (R = 0.65, P ≤ .001) and a main effect for symptom severity was observed (P ≤ .001). GAD-7 scores ≥11 and ≥17 represented the optimum specificity and sensitivity for detecting moderate and severe anxiety, respectively. CONCLUSIONS: The PARS and GAD-7 similarly reflect symptom severity. The GAD-7 is associated with acceptable specificity and sensitivity for detecting clinically significant anxiety symptoms. GAD-7 scores may be used to assess anxiety symptoms and to differentiate between mild and moderate GAD in adolescents, and may be more efficient than the PARS.
BACKGROUND: In pediatric patients with anxiety disorders, existing symptom inventories are either not freely available or require extensive time and effort to administer. We sought to evaluate a brief self-report scale-the Generalized Anxiety Disorder 7-item scale (GAD-7)-in adolescents with generalized anxiety disorder (GAD). METHODS: The Pediatric Anxiety Rating Scale (PARS) and the GAD-7 were administered to youth with GAD (confirmed by structured interview). Relationships between the measures were assessed, and sensitivity and specificity was determined with regard to a global symptom severity measure (Clinical Global Impression-Severity). RESULTS: In adolescents with GAD (N = 40; mean age, 14.8 ± 2.8), PARS and GAD-7 scores strongly correlated (R = 0.65, P ≤ .001) and a main effect for symptom severity was observed (P ≤ .001). GAD-7 scores ≥11 and ≥17 represented the optimum specificity and sensitivity for detecting moderate and severe anxiety, respectively. CONCLUSIONS: The PARS and GAD-7 similarly reflect symptom severity. The GAD-7 is associated with acceptable specificity and sensitivity for detecting clinically significant anxiety symptoms. GAD-7 scores may be used to assess anxiety symptoms and to differentiate between mild and moderate GAD in adolescents, and may be more efficient than the PARS.
Authors: Corinne Hannan; Michael J Lambert; Cory Harmon; Stevan Lars Nielsen; David W Smart; Kenichi Shimokawa; Scott W Sutton Journal: J Clin Psychol Date: 2005-02
Authors: Ronald C Kessler; Shelli Avenevoli; Jane Costello; Jennifer Greif Green; Michael J Gruber; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas Journal: Arch Gen Psychiatry Date: 2012-04
Authors: B Birmaher; S Khetarpal; D Brent; M Cully; L Balach; J Kaufman; S M Neer Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-04 Impact factor: 8.829
Authors: Jeffrey R Strawn; Apurva Prakash; Qi Zhang; Beth A Pangallo; Chad E Stroud; Na Cai; Robert L Findling Journal: J Am Acad Child Adolesc Psychiatry Date: 2015-01-29 Impact factor: 8.829
Authors: B Birmaher; D A Brent; L Chiappetta; J Bridge; S Monga; M Baugher Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-10 Impact factor: 8.829
Authors: Nicole E Caporino; Douglas M Brodman; Philip C Kendall; Anne Marie Albano; Joel Sherrill; John Piacentini; Dara Sakolsky; Boris Birmaher; Scott N Compton; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; John March; John T Walkup Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-11-30 Impact factor: 8.829
Authors: Jeffrey R Strawn; Scott T Aaronson; Ahmed Z Elmaadawi; G Randolph Schrodt; Richard C Holbert; Sarah Verdoliva; Karen Heart; Mark A Demitrack; Paul E Croarkin Journal: J Child Adolesc Psychopharmacol Date: 2020-04-21 Impact factor: 2.576
Authors: Corinne M Anton; Morgan B Drake; Ryan J Butts; Thi Cao; Afsaneh Rezaeizadeh; Madhukar H Trivedi; Kelli N Triplett Journal: J Clin Psychol Med Settings Date: 2021-03-27
Authors: Linh A Nguyen; Frans Pouwer; Paul Lodder; Esther Hartman; Per Winterdijk; Henk-Jan Aanstoot; Giesje Nefs Journal: Pediatr Res Date: 2021-03-04 Impact factor: 3.756
Authors: Eric T Dobson; Paul E Croarkin; Heidi K Schroeder; Sara T Varney; Sarah A Mossman; Kim Cecil; Jeffrey R Strawn Journal: J Affect Disord Date: 2020-11-11 Impact factor: 4.839